Evidence map›Paper›PMID 41465941›Full record

ArticleMedicine2025

A case of secondary oxalate nephropathy with nephrotic syndrome.

Minjie Weng, Chengqin Zha

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Minjie WengDepartment of Cardiology, Beilun People's Hospital, Ningbo, Zhejiang Province, China.ORCID 0009-0009-0337-3535
Chengqin ZhaDepartment of Nephrology, Beilun People's Hospital, Ningbo, Zhejiang Province, China.ORCID 0000-0002-1218-0323

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleNephrotic syndrome, caused by various etiologies and pathophysiological mechanisms, is occasionally complicated by secondary oxalate nephropathy-a rare and often underrecognized condition associated with Chinese herbal medicine use. The co-occurrence of nephrotic syndrome and oxalate nephropathy is extremely uncommon, and delayed diagnosis may lead to severe outcomes. PATIENT CONCERNS: A 19-year-old Chinese male presented with persistent edema for over 20 days and significant proteinuria. After taking traditional Chinese medicine for 20 days, his condition worsened rapidly, with new symptoms including infectious fever, erysipelas, acute renal failure, and heart failure. DIAGNOSES: The patient was diagnosed with nephrotic syndrome and acute oxalate nephropathy. Renal biopsy confirmed minimal change nephropathy (with possible focal segmental glomerulosclerosis) and acute tubulointerstitial injury with birefringent oxalate crystals in renal tubules.

interventionsA multidisciplinary treatment approach was adopted, including anti-infective therapy, volume expansion, diuresis, oral vitamin B6, methylprednisolone immunosuppression, and hemodialysis. OUTCOMES: After one month of glucocorticoid therapy, hemodialysis, and supportive care, urine output increased and renal function improved. The patient was discharged without requiring further hemodialysis. Outpatient follow-up showed normalized renal function, resolved proteinuria, and normal renal ultrasonography. LESSONS: Although traditional Chinese medicine is widely used in China, its potential to cause secondary oxalate nephropathy is often overlooked. Early renal biopsy is essential for accurate diagnosis and timely intervention in cases of nephrotic syndrome complicated by oxalate nephropathy.

Indexed as

Drugs, Chinese HerbalMedicine, Chinese TraditionalNephrotic SyndromeOxalatesAcute Kidney InjuryHumansMaleYoung AdultDrugs, Chinese HerbalOxalatesnephrotic syndromesecondary oxalate nephropathyTraditional Chinese Medicine

Identifiers

PMID41465941
PMCPMC12746954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.